Literature DB >> 12535082

Streptococcus pyogenes recruits collagen via surface-bound fibronectin: a novel colonization and immune evasion mechanism.

Katrin Dinkla1, Manfred Rohde, Wouter T M Jansen, Jonathan R Carapetis, Gursharan S Chhatwal, Susanne R Talay.   

Abstract

This study aimed to characterize matrix assembly mechanisms on the surface of the human pathogen Streptococcus pyogenes. Among 125 S. pyogenes isolates, 61% were able to recruit collagen type IV via surface-bound fibronectin. Streptococcus gordonii expressing the fibronectin-binding repeat domain of S. pyogenes SfbI protein was equally potent in recruiting collagen, indicating that this domain was sufficient to promote fibronectin-mediated collagen recruitment. Electron microscopic analysis of streptococci revealed that fibronectin-mediated collagen recruitment led to matrix deposition on and between streptococcal cells, which induced the formation of large bacterial aggregates. Furthermore, collagen-recruiting streptococci were able to colonize collagen fibres and were protected from adhering to human polymorphonuclear cells in the presence of opsonizing antibodies. Fibronectin-mediated collagen recruitment thus represents a novel aggregation, colonization and immune evasion mechanism of S. pyogenes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12535082     DOI: 10.1046/j.1365-2958.2003.03352.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  20 in total

1.  Collagen VI encodes antimicrobial activity: novel innate host defense properties of the extracellular matrix.

Authors:  Suado M Abdillahi; Selma Balvanović; Maria Baumgarten; Matthias Mörgelin
Journal:  J Innate Immun       Date:  2012-03-02       Impact factor: 7.349

Review 2.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

Review 3.  Streptococcus and rheumatic fever.

Authors:  Madeleine W Cunningham
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006

4.  Persistence of Streptococcus pyogenes in stationary-phase cultures.

Authors:  Daniel N Wood; Michelle A Chaussee; Michael S Chaussee; Bettina A Buttaro
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

5.  LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata.

Authors:  David E Hoke; Suhelen Egan; Paul A Cullen; Ben Adler
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

6.  Evolution of sfbI encoding streptococcal fibronectin-binding protein I: horizontal genetic transfer and gene mosaic structure.

Authors:  Rebecca J Towers; Peter K Fagan; Susanne R Talay; Bart J Currie; Kadaba S Sriprakash; Mark J Walker; Gursharan S Chhatwal
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

7.  Interactions with fibronectin attenuate the virulence of Streptococcus pyogenes.

Authors:  Patrik Nyberg; Takao Sakai; Kyu Hong Cho; Michael G Caparon; Reinhard Fässler; Lars Björck
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

Review 8.  Collagen-binding proteins of Streptococcus mutans and related streptococci.

Authors:  A Avilés-Reyes; J H Miller; J A Lemos; J Abranches
Journal:  Mol Oral Microbiol       Date:  2016-04-25       Impact factor: 3.563

9.  Identification of fibronectin-binding proteins in Mycoplasma gallisepticum strain R.

Authors:  Meghan May; Leka Papazisi; Timothy S Gorton; Steven J Geary
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

10.  Rheumatic fever-associated Streptococcus pyogenes isolates aggregate collagen.

Authors:  Katrin Dinkla; Manfred Rohde; Wouter T M Jansen; Edward L Kaplan; Gursharan S Chhatwal; Susanne R Talay
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.